Barclays PLC Standard Biotools Inc. Transaction History

Barclays PLC

$436 Billion
Q2 2025

A detailed history of Barclays PLC transactions in Standard Biotools Inc. stock. As of the latest transaction made, Barclays PLC holds 3,306,375 shares of LAB stock, worth $4.36 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,306,375

Previous 3,306,375 -0.0%

Holding current value

$4.36 Million

Previous $3.97 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$0.92 - $1.27 $189,369 - $261,411	205,836 Added 6.64%	3,306,375 $3.97 Million
Q1 2025 May 15, 2025	SELL	$1.01 - $2.06 $131,615 - $268,442	-130,312 Reduced 4.03%	3,100,539 $3.35 Million
Q4 2024 Feb 13, 2025	BUY	$1.5 - $2.26 $3,736 - $5,629	2,491 Added 0.08%	3,230,851 $5.65 Million
Q3 2024 Nov 15, 2024	BUY	$1.42 - $2.35 $535,616 - $886,408	377,195 Added 13.23%	3,228,360 $6.23 Million
Q2 2024 Aug 14, 2024	SELL	$1.65 - $2.92 $1.82 Million - $3.22 Million	-1,102,655 Reduced 27.89%	2,851,165 $5.05 Million
Q1 2024 May 15, 2024	BUY	$1.87 - $2.78 $7.09 Million - $10.5 Million	3,790,428 Added 2319.84%	3,953,820 $10.7 Million
Q4 2023 Feb 15, 2024	BUY	$1.59 - $2.73 $183,164 - $314,490	115,198 Added 239.03%	163,392 $361,000
Q3 2023 Nov 07, 2023	BUY	$1.9 - $3.05 $91,568 - $146,991	48,194 New	48,194 $140,000
Q1 2023 May 04, 2023	BUY	$1.3 - $2.24 $35,600 - $61,342	27,385 New	27,385 $53,000
Q2 2022 Aug 12, 2022	SELL	$1.6 - $3.99 $19,995 - $49,863	-12,497 Reduced 98.35%	210 $0
Q1 2022 May 16, 2022	SELL	$2.8 - $3.96 $223,356 - $315,889	-79,770 Reduced 86.26%	12,707 $45,000
Q4 2021 Feb 14, 2022	BUY	$3.63 - $6.13 $222,667 - $376,020	61,341 Added 197.01%	92,477 $362,000
Q3 2021 Nov 09, 2021	BUY	$5.5 - $7.41 $118,442 - $159,574	21,535 Added 224.3%	31,136 $205,000
Q2 2021 Aug 13, 2021	SELL	$4.35 - $6.35 $227,304 - $331,812	-52,254 Reduced 84.48%	9,601 $60,000
Q1 2021 May 13, 2021	BUY	$3.94 - $7.09 $149,601 - $269,207	37,970 Added 158.97%	61,855 $279,000
Q4 2020 Feb 11, 2021	SELL	$5.45 - $8.65 $521,521 - $827,735	-95,692 Reduced 80.03%	23,885 $144,000
Q3 2020 Nov 12, 2020	BUY	$4.34 - $11.43 $8,337 - $21,957	1,921 Added 1.63%	119,577 $888,000
Q2 2020 Aug 12, 2020	SELL	$1.85 - $5.29 $15,153 - $43,330	-8,191 Reduced 6.51%	117,656 $472,000
Q1 2020 May 13, 2020	BUY	$1.24 - $4.35 $70,149 - $246,088	56,572 Added 81.66%	125,847 $319,000
Q4 2019 Feb 10, 2020	BUY	$2.3 - $5.12 $43,877 - $97,674	19,077 Added 38.0%	69,275 $241,000
Q3 2019 Nov 14, 2019	BUY	$4.63 - $12.15 $12,246 - $32,136	2,645 Added 5.56%	50,198 $233,000
Q2 2019 Aug 14, 2019	BUY	$11.49 - $14.17 $193,273 - $238,353	16,821 Added 54.73%	47,553 $586,000
Q1 2019 May 15, 2019	BUY	$8.47 - $14.36 $259,901 - $440,636	30,685 Added 65287.23%	30,732 $408,000
Q4 2018 Feb 14, 2019	SELL	$7.18 - $8.83 $363,544 - $447,089	-50,633 Reduced 99.91%	47 $0
Q3 2018 Nov 14, 2018	BUY	$5.92 - $8.35 $279,720 - $394,537	47,250 Added 1377.55%	50,680 $380,000
Q2 2018 Aug 14, 2018	SELL	$4.86 - $6.24 $36,367 - $46,693	-7,483 Reduced 68.57%	3,430 $21,000
Q1 2018 May 15, 2018	BUY	$5.75 - $7.97 $27,387 - $37,961	4,763 Added 77.45%	10,913 $63,000
Q4 2017 Feb 14, 2018	BUY	$4.46 - $6.45 $19,744 - $28,554	4,427 Added 256.94%	6,150 $36,000
Q3 2017 Nov 14, 2017	BUY	$3.55 - $5.49 $6,116 - $9,459	1,723	1,723 $8,000

Others Institutions Holding LAB

# of Institutions

166

Shares Held

278M

Call Options Held

34.9K

Put Options Held

View Full List

About STANDARD BIOTOOLS INC.

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $104M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

More about LAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account